Alterity Therapeutics Files 6-K on Substantial Holding Change
Ticker: PRNAF · Form: 6-K · Filed: Apr 8, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: substantial-holding, corporate-action, filing-update
Related Tickers: ATHE
TL;DR
Alterity Therapeutics (ATHE) filed a 6-K for a change in substantial holding – watch for investor moves.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on April 8, 2025, to report a change in substantial holding. This filing is incorporated by reference into several of their existing Registration Statements on Form S-8 and Form F-3. The company, formerly known as PRANA BIOTECHNOLOGY LTD, is a development stage enterprise based in Melbourne, Australia.
Why It Matters
Changes in substantial holdings can indicate shifts in major investor confidence or strategy, potentially impacting the stock price.
Risk Assessment
Risk Level: medium — Form 6-K filings often relate to corporate actions or changes in significant shareholdings, which can introduce volatility.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- PRANA BIOTECHNOLOGY LTD (company) — Former company name
- April 8, 2025 (date) — Filing date
- 333-251073 (filing_id) — Form S-8 registration statement file number
- 333-274816 (filing_id) — Form F-3 registration statement file number
FAQ
What specific event triggered the 'change in substantial holding' filing?
The filing itself, Exhibit 99.1, details the 'Change in substantial holding', but the specific event is not described in the provided text of the 6-K header.
Which of Alterity Therapeutics' registration statements is this 6-K being incorporated into?
This Form 6-K is being incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What is Alterity Therapeutics Limited's principal executive office address?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
When did Alterity Therapeutics Limited change its name from PRANA BIOTECHNOLOGY LTD?
The date of the name change from PRANA BIOTECHNOLOGY LTD was January 5, 2001.
What is the SIC code for Alterity Therapeutics Ltd?
The Standard Industrial Classification (SIC) code for Alterity Therapeutics Ltd is 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 8, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).